Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology industry, specializing in the development of essential biological reagents and supplements that facilitate advancements in life sciences research and biomanufacturing. The company's innovative offerings are integral to high-demand sectors, including vaccine development, cell and gene therapy, and diagnostic testing, underscoring its commitment to quality and superior customer support. With a robust biotechnology foundation and a focus on innovation, Alpha Teknova is well-positioned to capitalize on growth opportunities within the rapidly evolving life sciences market, enhancing its appeal to institutional investors seeking strategic investments.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$6.89
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 5, 2026 | $-0.08 | $-0.06 | Beat +25.0% | $-0.06 | $10.91M | $12.19M | +11.7% | 1D Pre+4.2% | On-Day+1.6% | 1D Post+16.4% |
Q ended Mar 31, 2026 Reported May 6, 2026 | $-0.09 | $-0.08 | Beat +11.1% | $-0.08 | $10.33M | $11.08M | +7.3% | 1D Pre+4.2% | On-Day-2.7% | 1D Post+9.9% |
Q ended Dec 31, 2025 Reported Feb 26, 2026 | $-0.09 | $-0.09 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| $9.61M |
| $9.98M |
| +3.9% |
| 1D Pre0.0% |
| On-Day+0.9% |
| 1D Post+13.2% |
Q ended Sep 30, 2025 Reported Nov 6, 2025 | $-0.10 | $-0.08 | Beat +20.0% | — | $10.28M | $10.45M | +1.7% | 1D Pre+4.2% | On-Day-2.8% | 1D Post-2.1% |